Neuroprotective effects of cardiotrophin-like cytokine on retinal ganglion cells

Frank Schuettauf, David Zurakowski, Kristine Quinto, Meghana A. Varde, Dorothea Besch, Alan Laties, Ralph Anderson, Rong Wen

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background: Premature neuronal cell death is a feature of numerous central nervous system and eye diseases, including glaucoma. Neurons (including retinal ganglion cells, RGCs) are protected by several neurotrophic factors, among those the IL-6 family of cytokines. Lately, a novel member of the IL-6 family of cytokines has been identified and cloned. This cytokine is known as novel neurotrophin-1/ B-cell-stimulating factor-3 (NNT-1/BSF-3) or cardiotrophin-like cytokine (CLC). It shows neurotrophic as well as B-cell stimulatory effects. Methods: In this study, the neuroprotective properties of CLC on RGC loss in vivo were investigated. Results: CLC significantly protected RGCs from degeneration in both chosen models of retinal neuronal damage: optic nerve crush (P<0.01) and N-methyl-D-aspartate (NMDA) injection (P<0.001). Conclusions: CLC shows neuroprotective effects on RGCs in vivo and might be a treatment option for chronic neurodegenerative eye diseases such as glaucoma. Clinical feasibility for the substance requires further investigation since the immunomodulatory and possible adverse effects have not yet been thoroughly characterized.

Original languageEnglish
Pages (from-to)1036-1042
Number of pages7
JournalGraefe's Archive for Clinical and Experimental Ophthalmology
Volume243
Issue number10
DOIs
StatePublished - Oct 1 2005
Externally publishedYes

Fingerprint

Retinal Ganglion Cells
Neuroprotective Agents
Eye Diseases
Nerve Growth Factors
Cytokines
Interleukin-4
Glaucoma
Interleukin-6
Nerve Crush
Central Nervous System Diseases
N-Methylaspartate
Optic Nerve
Neurodegenerative Diseases
B-Lymphocytes
Cell Death
Neurons
Injections
cardiotrophin-like cytokine
Therapeutics

Keywords

  • Cytokines
  • Excitotoxicity
  • Neuroprotection
  • Opticnerve crush
  • Retinal ganglion cells

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Neuroprotective effects of cardiotrophin-like cytokine on retinal ganglion cells. / Schuettauf, Frank; Zurakowski, David; Quinto, Kristine; Varde, Meghana A.; Besch, Dorothea; Laties, Alan; Anderson, Ralph; Wen, Rong.

In: Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 243, No. 10, 01.10.2005, p. 1036-1042.

Research output: Contribution to journalArticle

Schuettauf, F, Zurakowski, D, Quinto, K, Varde, MA, Besch, D, Laties, A, Anderson, R & Wen, R 2005, 'Neuroprotective effects of cardiotrophin-like cytokine on retinal ganglion cells', Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 243, no. 10, pp. 1036-1042. https://doi.org/10.1007/s00417-005-1152-7
Schuettauf, Frank ; Zurakowski, David ; Quinto, Kristine ; Varde, Meghana A. ; Besch, Dorothea ; Laties, Alan ; Anderson, Ralph ; Wen, Rong. / Neuroprotective effects of cardiotrophin-like cytokine on retinal ganglion cells. In: Graefe's Archive for Clinical and Experimental Ophthalmology. 2005 ; Vol. 243, No. 10. pp. 1036-1042.
@article{db2c3e56c35e48579047f2091f0fe45c,
title = "Neuroprotective effects of cardiotrophin-like cytokine on retinal ganglion cells",
abstract = "Background: Premature neuronal cell death is a feature of numerous central nervous system and eye diseases, including glaucoma. Neurons (including retinal ganglion cells, RGCs) are protected by several neurotrophic factors, among those the IL-6 family of cytokines. Lately, a novel member of the IL-6 family of cytokines has been identified and cloned. This cytokine is known as novel neurotrophin-1/ B-cell-stimulating factor-3 (NNT-1/BSF-3) or cardiotrophin-like cytokine (CLC). It shows neurotrophic as well as B-cell stimulatory effects. Methods: In this study, the neuroprotective properties of CLC on RGC loss in vivo were investigated. Results: CLC significantly protected RGCs from degeneration in both chosen models of retinal neuronal damage: optic nerve crush (P<0.01) and N-methyl-D-aspartate (NMDA) injection (P<0.001). Conclusions: CLC shows neuroprotective effects on RGCs in vivo and might be a treatment option for chronic neurodegenerative eye diseases such as glaucoma. Clinical feasibility for the substance requires further investigation since the immunomodulatory and possible adverse effects have not yet been thoroughly characterized.",
keywords = "Cytokines, Excitotoxicity, Neuroprotection, Opticnerve crush, Retinal ganglion cells",
author = "Frank Schuettauf and David Zurakowski and Kristine Quinto and Varde, {Meghana A.} and Dorothea Besch and Alan Laties and Ralph Anderson and Rong Wen",
year = "2005",
month = "10",
day = "1",
doi = "10.1007/s00417-005-1152-7",
language = "English",
volume = "243",
pages = "1036--1042",
journal = "Albrecht von Graefes Archiv für Klinische und Experimentelle Ophthalmologie",
issn = "0065-6100",
publisher = "Springer Verlag",
number = "10",

}

TY - JOUR

T1 - Neuroprotective effects of cardiotrophin-like cytokine on retinal ganglion cells

AU - Schuettauf, Frank

AU - Zurakowski, David

AU - Quinto, Kristine

AU - Varde, Meghana A.

AU - Besch, Dorothea

AU - Laties, Alan

AU - Anderson, Ralph

AU - Wen, Rong

PY - 2005/10/1

Y1 - 2005/10/1

N2 - Background: Premature neuronal cell death is a feature of numerous central nervous system and eye diseases, including glaucoma. Neurons (including retinal ganglion cells, RGCs) are protected by several neurotrophic factors, among those the IL-6 family of cytokines. Lately, a novel member of the IL-6 family of cytokines has been identified and cloned. This cytokine is known as novel neurotrophin-1/ B-cell-stimulating factor-3 (NNT-1/BSF-3) or cardiotrophin-like cytokine (CLC). It shows neurotrophic as well as B-cell stimulatory effects. Methods: In this study, the neuroprotective properties of CLC on RGC loss in vivo were investigated. Results: CLC significantly protected RGCs from degeneration in both chosen models of retinal neuronal damage: optic nerve crush (P<0.01) and N-methyl-D-aspartate (NMDA) injection (P<0.001). Conclusions: CLC shows neuroprotective effects on RGCs in vivo and might be a treatment option for chronic neurodegenerative eye diseases such as glaucoma. Clinical feasibility for the substance requires further investigation since the immunomodulatory and possible adverse effects have not yet been thoroughly characterized.

AB - Background: Premature neuronal cell death is a feature of numerous central nervous system and eye diseases, including glaucoma. Neurons (including retinal ganglion cells, RGCs) are protected by several neurotrophic factors, among those the IL-6 family of cytokines. Lately, a novel member of the IL-6 family of cytokines has been identified and cloned. This cytokine is known as novel neurotrophin-1/ B-cell-stimulating factor-3 (NNT-1/BSF-3) or cardiotrophin-like cytokine (CLC). It shows neurotrophic as well as B-cell stimulatory effects. Methods: In this study, the neuroprotective properties of CLC on RGC loss in vivo were investigated. Results: CLC significantly protected RGCs from degeneration in both chosen models of retinal neuronal damage: optic nerve crush (P<0.01) and N-methyl-D-aspartate (NMDA) injection (P<0.001). Conclusions: CLC shows neuroprotective effects on RGCs in vivo and might be a treatment option for chronic neurodegenerative eye diseases such as glaucoma. Clinical feasibility for the substance requires further investigation since the immunomodulatory and possible adverse effects have not yet been thoroughly characterized.

KW - Cytokines

KW - Excitotoxicity

KW - Neuroprotection

KW - Opticnerve crush

KW - Retinal ganglion cells

UR - http://www.scopus.com/inward/record.url?scp=27744491934&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27744491934&partnerID=8YFLogxK

U2 - 10.1007/s00417-005-1152-7

DO - 10.1007/s00417-005-1152-7

M3 - Article

C2 - 15838664

AN - SCOPUS:27744491934

VL - 243

SP - 1036

EP - 1042

JO - Albrecht von Graefes Archiv für Klinische und Experimentelle Ophthalmologie

JF - Albrecht von Graefes Archiv für Klinische und Experimentelle Ophthalmologie

SN - 0065-6100

IS - 10

ER -